CQuentia offers Verifi™ Prenatal Tests to safely and non-invasively screen for the most common chromosomal aneuploidies as early as 10 weeks gestation using a single maternal blood draw. Genome sequencing is the most advanced technique for performing noninvasive prenatal testing with excellent detection rates and very low false positive rates. Developed by Illumina, the Verifi™ Prenatal Test uses whole-genome sequencing (WGS), carried out in our CLIA-certified laboratory, to screen for common fetal aneuploidies to provide accurate information for pregnant women regardless of age or risk from as early as 10 weeks gestation until term.